Insulin Glargine (Lantus) from Japan

Long-acting basal insulin analogue produced by recombinant DNA, modified for prolonged release profile. HTS 2937.12.00.00 covers this as a derivative and structural analogue of insulin used primarily as a hormone. Chemically defined polypeptide meeting Chapter 29 hormone classification criteria.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Import Tips

Provide recombinant production method validation and amino acid sequence confirmation

Temperature-controlled shipping mandatory (2-8°C); include continuous monitoring records

Pure substance declaration prevents reclassification as Chapter 30 pharmaceutical product